Abbott Biotechnology Ltd.
Records under this name other than the patents Abbott Biotechnology Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Back to Abbott Biotechnology Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,061,005 | Multiple-variable dose regimen for treating idiopathic inflammatory bowel disease Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US D677,380 | Automatic injection device Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,486,584 | Automatic injection device Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,231,876 | Purified antibody composition Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,883,156 | Purified antibody composition Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,895,009 | Purified antibody composition Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,906,372 | Purified antibody composition Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,916,153 | Purified antibody composition Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,715,664 | Use of human TNFα antibodies for treatment of erosive polyarthritis Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,919,264 | Methods and compositions for determining the efficacy of a treatment for ankylosing spondylitis using biomarkers Formerly held In force · From the USPTO record | In force | From the USPTO record |